Position in DTIL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$539,015
-$688,458 QoQ
Shares Held
68,577
-69.3% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 95 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. DTIL ranks #211 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in DTIL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $539,015 | 68,577 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,227,473 | 223,177 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,358,144 | 326,477 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,082,897 | 196,177 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $337,163 | 80,277 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $395,800 | 82,977 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $418,330 | 109,798 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $722,158 | 80,598 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $807,570 | 82,998 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,349,192 | 99,498 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $945,792 | 2,591,212 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $542,897 | 1,592,074 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $902,964 | 1,716,663 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,150,858 | 1,526,338 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,881,078 | 1,580,738 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,824,465 | 2,172,666 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,450,862 | 906,789 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $718,798 | 233,376 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $150,959 | 20,400 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $1,266,084 | 101,125 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,308,633 | 126,438 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $309,730 | 37,138 | Shares | Sole | 2021-02-10 | |
| 2020-03-31 | $540,601 | 89,652 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||